Evidence map›Paper›PMID 39899361›Full record

ReviewClinical science (London, England : 1979)2025

Therapeutic strategies to ameliorate mitochondrial oxidative stress in ischaemia-reperfusion injury: A narrative review.

Khalid Alotaibi, Nishkantha Arulkumaran, Alex Dyson, Mervyn Singer

Abstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Khalid AlotaibiBloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, U.K.ORCID 0009-0001-0522-5327
Nishkantha ArulkumaranBloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, U.K.
Alex DysonBloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, U.K.ORCID 0000-0001-8334-9432
Mervyn SingerBloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, U.K.ORCID 0000-0002-1042-6350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial reactive oxygen species (mROS) play a crucial physiological role in intracellular signalling. However, high levels of ROS can overwhelm antioxidant defences and lead to detrimental modifications in protein, lipid and DNA structure and function. Ischaemia-reperfusion injury is a multifaceted pathological state characterised by excessive production of mROS. There is a significant clinical need for therapies mitigating mitochondrial oxidative stress. To date, a variety of strategies have been investigated, ranging from enhancing antioxidant reserve capacity to metabolism reduction. While success has been achieved in non-clinical models, no intervention has yet successfully transitioned into routine clinical practice. In this article, we explore the different strategies investigated and discuss the possible reasons for the lack of translation.

Indexed as

AntioxidantsMitochondriaOxidative StressReperfusion InjuryAnimalsHumansReactive Oxygen SpeciesAntioxidantsReactive Oxygen Speciesantioxidantischaemia-reperfusion injurymitochondriamROSoxidative stress

Identifiers

PMID39899361
PMCPMC12204024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.